LMR Partners’s ProKidney PROK Stock Holding History

LMR Partners’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,484	Closed	-$22.3K	–	1729
2026 Q1	$22.3K	Buy	+12,484	New	+$26.5K	﹤0.01%	1346

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LMR Partners's PROK Position: Q2 2026 in Review

LMR Partners sold out of ProKidney (PROK) in Q2 2026, closing a stake of 12,484 shares — an estimated $22.3K sold.

LMR Partners first reported a position in PROK in Q1 2026 and held it in 1 quarter. The position peaked at $22.3K in Q1 2026. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

LMR Partners reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
LMR Partners sold 12,484 ProKidney shares in Q2 2026, an estimated $22.3K.
LMR Partners first reported a position in ProKidney in Q1 2026 and held it in 1 quarter.
LMR Partners's ProKidney position peaked at $22.3K in Q1 2026.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.